Page 29 - Delaware Medical Journal - January/February 2019
P. 29

ORIGINAL RESEARCH
    TABLE 1. HPV vaccination (≥ 1 dose ) among respondents aged 18-29 years, by state and year — Behavioral Risk Factor Surveillance System, United States, 2011 to 2016
     2011
% (95%CI)
 2012
% (95%CI)
 2013
% (95%CI)
   2014
% (95%CI)
 2015
% (95%CI)
 2016
% (95%CI)
   United States
  16.8 (13.7-20.0)
  18.6 (17.0-20.1)
 29.0 (26.8-31.3)
   28.0 (26.3-29.6)
  32.1 (29.6-34.6)
  23.8 (21.8-25.7)
   Alabama
    15.0 (11.8-18.1)
    19.5 (15.9-23.2)
    26.0 (22.1-29.9)
   Arizona
    17.8 (13.8-21.7)
           Connecticut
  24.0 (18.7-29.4)
  26.6 (22.4-30.9)
 32.5 (27.0-38.0)
       34.3 (30.1-38.6)
   Delaware
    31.5 (26.8-36.3)
    35.9 (29.1-42.6)
       Georgia
            24.6 (19.9-29.2)
   31.5 (25.3-37.8)
      Hawaii
  23.6 (19.7-27.5)
    20.5 (16.9-24.1)
   Indiana
            22.2 (19.0-25.5)
         Maine
  20.4 (15.6-25.2)
       Massachusetts
    29.3 (26.4-32.2)
 33.2 (29.3-37.2)
   40.2 (36.3-44.2)
  43.4 (39.0-47.8)
     Minnesota
        29.8 (27.2-32.4)
       Mississippi
     15.7 (12.1-19.3)
          Missouri
          26.5(21.7-31.3)
  28.5 (22.9-34.2)
   Nebraska
            25.4 (22.1-28.7)
   North Carolina
            27.9 (23.7-32.0)
   Rhode Island
     36.4 (30.9-41.9)
   41.2 (35.5-46.8)
       South Carolina
          24.0 (20.6-27.4)
  23.2 (19.6-26.7)
   South Dakota
                  25.2 (19.5-30.8)
   Tennessee
 10.9 (5.2-16.5)
        Texas
    11.6 (8.5-14.7)
        18.6 (14.4-22.7)
   West Virginia
    16.4 (12.8-20.1)
      31.3 (27.3-35.4)
     Wisconsin
  17.5 (12.4-22.6)
           Wyoming
       23.4 (16.7-30.0)
           immunization (43.4%). In 2016, nine states completed the HPV module (Alabama, Connecticut, Hawaii, Missouri, Nebraska, North Carolina, South Carolina, South Dakota, and Texas). 23.8% of the overall respondents had received an HPV vaccine in 2016, with Connecticut leading HPV immunization (34.3%).
On analyses by selected characteristics
for each of the study years (Table 2;       provided in Table 2 for each year), HPV vaccination coverage was found to be       difference was consistent across all study years. Having health insurance and having     
associated with higher prevalence of
HPV vaccination. Being unmarried was        higher prevalence of HPV vaccination for some years.
     
race, education, income, and receiving an HIV test (Table 2).
Initiation of HPV vaccination among females aged 18-29 years For the combined data (2013-2016),
a total of 9,142 women answered
HPV vaccination questions in the BRFSS survey. Overall, 4,199 (44.7%) women ever had an HPV vaccination. The initiation of HPV vaccination
among women differed by selected
  
in HPV initiation were found by race, education, income, insurance, MSA status, marital status, having a personal doctor, and having received an HIV test (Table 3). By race, the prevalence of HPV initiation was lower among blacks (39.6%) and Hispanics (33.4%) as compared to white females (51.1%, p<.0001). HPV vaccination was lower among women living in non-MSA areas (35%, p=.0068), women who were single (32.2%) or in
a (married or other) couple relationship (36.8%, p<.0001), women with less than high school education (36%, p<.0001), women with a lower income (41%, p<.0001), and uninsured women (30.4%,
   Del Med J | January/February 2019 | Vol. 91 | No. 1
29


   27   28   29   30   31